News from Weill Cornell Medical College
Weill Cornell Medical College Creates Office of Faculty Development
January 26, 2012 Weill Cornell Medical College has announced the establishment of the Office of Faculty Development dedicated to assisting its physicians, researchers and educators in achieving academic success at each stage of their careers, with targeted activities that focus on the needs of junior, mid-career and senior faculty. [more]
More Press Releases
Taking Moments to Enjoy Life Helps Patients Make Better Health Decisions
January 23, 2012 The experience of daily positive affect — a mild, happy feeling — and self-affirmation helps some patients with chronic diseases, including coronary artery disease, high blood pressure and asthma, make better decisions about their health. These findings are detailed in three studies of 756 patients published online in the Jan. 23 edition of the Archives of Internal Medicine — the first large, randomized controlled trials to show that people can use positive affect and self-affirmation to help them make and sustain behavior change.
January 23, 2012 The experience of daily positive affect — a mild, happy feeling — and self-affirmation helps some patients with chronic diseases, including coronary artery disease, high blood pressure and asthma, make better decisions about their health. These findings are detailed in three studies of 756 patients published online in the Jan. 23 edition of the Archives of Internal Medicine — the first large, randomized controlled trials to show that people can use positive affect and self-affirmation to help them make and sustain behavior change.
Aspirin Merits Testing for Prevention of Cervical Cancer in HIV-Infected Women
January 18, 2012 Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women.
January 18, 2012 Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women.
